SBP

NEVER BEFORE HAVE VETERANS WITH CHRONIC OR TERMINAL ILLNESS HAD ONE VALUABLE SOURCE FOR ALL INFORMATION ABOUT THEIR RIGHTS AND BENEFITS. NOW THEY DO!

Retrieved on: 
Friday, November 11, 2022
Woman, SBP, Veterans' affairs, Defense Finance and Accounting Service, Health care, Man, NPHI, National Partnership, District, United States Department of Veterans Affairs, Family, Review, Arizona Department of Veterans' Services, Veterans Day, Pay, Organization, Caregiver, Patient, Guide, Palliative care, Goal, Veterans Benefits Administration, Hospice, State, Department, Edward Hines Jr. Veterans Administration Hospital, Health insurance, Veteran

These men and women earned precious benefits for their service, and many of those benefits are often underutilized or difficult to access.

Key Points: 
  • These men and women earned precious benefits for their service, and many of those benefits are often underutilized or difficult to access.
  • The Veteran Benefits and Resources for Hospice and Palliative Care Patients guide includes information for veterans and their families regarding military pay, retirement pay, and survivor benefits through the Defense Finance and Accounting Services.
  • It provides information on qualifying for disability benefits, a military history checklist, and national plus local points of contact.
  • The team offered the Veterans Resource Guide to the family, and they were very grateful to have it to review.

CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data on Baxdrostat in Treatment-Resistant Hypertension at the 2022 American Heart Association Scientific Sessions

Retrieved on: 
Monday, November 7, 2022
GLOBE, DBP, American College of Cardiology, Plasma, Renin, Death, Adult, M.D, U.S. Securities and Exchange Commission, AHA, CKD, Risk, American College, Plasma protein binding, Hypertension, Population, Conference call, Degenerative disease, SEC, Annual report, Cardiology, ID, Safety, Achievement, Time, Aldosterone, Hyponatremia, Conference, Patient, Urine, American Heart Association, Primary aldosteronism, Kidney, Hypotension, Potassium, Blood pressure, Kidney disease, SBP, Security (finance), COVID-19, Stroke, Phosphorus, Pharmaceutical industry, Collection

WALTHAM, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) announced the presentation today of Phase 2 data from its BrigHtn trial as part of the late-breaking science session at the 2022 American Heart Association (AHA) Scientific Sessions. Baxdrostat is a highly selective, once daily oral small molecule inhibitor of aldosterone synthase.

Key Points: 
  • Baxdrostat significantly decreases aldosterone in plasma and urine, while increasing plasma renin as a physiological compensatory change.
  • These changes in aldosterone and renin following treatment with baxdrostat reflect less salt exposure to the kidney and reduced blood pressure over time.
  • And, unlike earlier generations of aldosterone synthase inhibitors, serum cortisol levels were not reduced, once again confirming the highly selective mechanism of baxdrostat.
  • Though often asymptomatic, hypertension significantly increases the risk of heart disease, stroke, and kidney disease, amongst other diseases.

Correcting and Replacing: CinCor Reports Third Quarter Financial Results and Provides Corporate Update

Retrieved on: 
Friday, November 4, 2022
American Heart Association, Blood pressure, G&A, CINC, Society, OLE, Population, Adult, SBP, Income, Research, Research and development, Annual report, U.S. Securities and Exchange Commission, ET, CMC, Aldosterone, R, SEC, Administration, Disclosure, American College, MAD, Congress, GLOBE, International Society, Mercury (element), IPO, Death, Security (finance), Patient, Units of paper quantity, American College of Cardiology, Primary aldosteronism, Risk, ESC, European Society of Cardiology, COVID-19, Plasma protein binding, AHA, Chemistry, Kidney disease, Investment, Time, Publication, Degenerative disease, Safety, Stroke, CKD, ASN, American Society of Nephrology, ISH, NASDAQ, Achievement, Pharmaceutical industry, Collection, Hypertension, Cardiology

We are thrilled with the positive topline data reported for baxdrostat in treatment-resistant hypertension earlier this quarter.

Key Points: 
  • We are thrilled with the positive topline data reported for baxdrostat in treatment-resistant hypertension earlier this quarter.
  • We look forward to providing an update once the HALO trial data has been unblinded and analyzed, which is anticipated before year-end 2022.
  • In August 2022, CinCor reported positive topline data for the Phase 2 BrigHtn trial evaluating baxdrostat for patients with rHTN.
  • In October, CinCor announced the publication of the Phase 1 Multiple Ascending Dose Study Data in the journal, Hypertension Research.

CinCor Reports Third Quarter Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, November 3, 2022
American Heart Association, Blood pressure, G&A, CINC, Society, OLE, Population, Adult, SBP, Income, Research, Research and development, Annual report, U.S. Securities and Exchange Commission, CMC, Aldosterone, R, SEC, Administration, Disclosure, American College, MAD, Congress, GLOBE, International Society, Mercury (element), IPO, Death, Security (finance), Patient, Units of paper quantity, American College of Cardiology, Primary aldosteronism, Risk, ESC, European Society of Cardiology, COVID-19, Plasma protein binding, AHA, Chemistry, Kidney disease, Investment, Time, Publication, Degenerative disease, HALO, Safety, Stroke, CKD, ASN, American Society of Nephrology, ISH, NASDAQ, Achievement, Pharmaceutical industry, Collection, Hypertension, Cardiology

WALTHAM, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced financial results for the third quarter ended September 30, 2022 and provided a corporate update.

Key Points: 
  • We are thrilled with the positive topline data reported for baxdrostat in treatment-resistant hypertension earlier this quarter.
  • In August 2022, CinCor reported positive topline data for the Phase 2 BrigHtn trial evaluating baxdrostat for patients with rHTN.
  • In October, CinCor announced the publication of the Phase 1 Multiple Ascending Dose Study Data in the journal, Hypertension Research.
  • CinCor undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.

Bristol Myers Squibb Announces Positive Topline Results of Phase 3 COMMANDS Trial

Retrieved on: 
Monday, October 31, 2022
Biotechnology, Pharmaceutical, Health, Clinical Trials, People, Hepatomegaly, Beta thalassemia, Safety, Hypertension, Myelodysplastic syndrome, Deep vein thrombosis, DBP, History, MDS, Splenomegaly, SBP, EMH, Patient, The Bristol-Myers Squibb Children's Hospital, BMY, RBC, NYSE, Risk, Stroke, ESA, Spinal cord compression, Adult, Clinical trial, Anemia, Acquisition, Iron overload, Embolism, HB, Lymphatic system, Merck, Portal vein thrombosis, Bristol Myers Squibb, Microdeletion syndrome, Incidence, TEE, Splenectomy, Thrombosis, Hormone replacement therapy, Pharmaceutical industry, Blood product

We are pleased with the positive results of the COMMANDS study and look forward to presenting these important data.

Key Points: 
  • We are pleased with the positive results of the COMMANDS study and look forward to presenting these important data.
  • Bristol Myers Squibb will complete a full evaluation of the COMMANDS data and work with investigators to present detailed results at an upcoming medical meeting, as well as discuss these results with health authorities.
  • Bristol Myers Squibb thanks the patients and investigators who are participating in the COMMANDS clinical trial.
  • For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn , Twitter , YouTube , Facebook and Instagram .

AmeriCorps Reports $12 Return per Dollar Invested in Disaster Relief

Retrieved on: 
Monday, October 17, 2022
Time, Government, Disaster, Employment, Organization, AmeriCorps, Volunteering, National, Result, Program, ROI, Welfare, GLOBE, Â, Pacific typhoon season, SBP, Federal Standard 1037C, Risk management, Tutoring

WASHINGTON, DC, Oct. 17, 2022 (GLOBE NEWSWIRE) -- National service disaster response efforts return as much as $11.96 for every federal dollar invested, according to a study issued by AmeriCorps , the federal agency for national service and volunteerism.

Key Points: 
  • WASHINGTON, DC, Oct. 17, 2022 (GLOBE NEWSWIRE) -- National service disaster response efforts return as much as $11.96 for every federal dollar invested, according to a study issued by AmeriCorps , the federal agency for national service and volunteerism.
  • The return-on-investment study focused on the value of federal funding invested in SBP AmeriCorps , a national organization that engages in disaster recovery efforts across the country.
  • ROI analyses of national service programs estimate the monetary value of benefits that a program generates per dollar invested.
  • AmeriCorps disaster response is a core focus area for the agency as we continue to make AmeriCorps members and staff available following mass disaster declarations, said Michael D. Smith, AmeriCorps CEO.

Trex Teams With DW Distribution to Expand and Elevate Service in the South Central Region

Retrieved on: 
Wednesday, October 5, 2022
Commercial Building & Real Estate, Construction & Property, Finance, Banking, Landscape, Professional Services, Building Systems, Architecture, Other Construction & Property, Residential Building & Real Estate, YouTube, Distribution, Trex Company, Inc., Twitter, IndustryWeek, Industry, Specialty, Trex, DW, Maintenance, SBP, Wood, Oil, Instagram, Facebook, Houzz

Dallas Wholesale Distribution ( DW Distribution ), a Specialty Building Products, Inc. (SBP) brand, has teamed with Trex Company to further expand availability of the brands industry-leading decking and outdoor living products across the South Central region.

Key Points: 
  • Dallas Wholesale Distribution ( DW Distribution ), a Specialty Building Products, Inc. (SBP) brand, has teamed with Trex Company to further expand availability of the brands industry-leading decking and outdoor living products across the South Central region.
  • DW Distribution has a well-earned reputation for providing outstanding service to its customers and boasts some of the best distributor sales representatives and management in the industry.
  • Headquartered in DeSoto, DW Distribution was founded in 1955 and has been operating as an SBP brand since 2021.
  • We are pleased to expand our relationship with Trex Company and its products, programs and people, said David Cusey, vice president of building materials for DW Distribution.

Clinton Global Initiative Highlights SBP's Innovative Disaster Recovery Solutions

Retrieved on: 
Wednesday, September 21, 2022
HUD, Disaster, Volunteering, City, Survivor, Program, SBP, CEO, CGI, Solution, Hurricane Katrina, Multimedia, Commitment, Color, Lists of disasters, RAF, Renewable energy, Insurance

NEW YORK, Sept. 21, 2022 /PRNewswire/ -- On Tuesday, The Clinton Global Initiative announced the innovative work of SBP, a Louisiana-based social impact organization focused on disaster resilience and recovery. SBP's Recovery Acceleration Fund (RAF), a new program that taps private investment to shorten the time it takes for financial support to reach disaster survivors seeking home repair assistance, earned recognition as a featured Commitment to Action at CGI's 2022 meeting. While survivors must often wait more than two years after a natural disaster to receive HUD assistance, the RAF will quickly provide bridge loans to finance home rebuilds for under-resourced survivors.

Key Points: 
  • NEW YORK, Sept. 21, 2022 /PRNewswire/ -- On Tuesday, The Clinton Global Initiative announced the innovative work of SBP, a Louisiana-based social impact organization focused on disaster resilience and recovery.
  • The Recovery Acceleration Fund will begin to reshape the way disaster recovery works in America - in favor of survivors.
  • "We are honored that the Clinton Global Initiative has recognized SBP's transformative work to help communities recover from disasters," said Zack Rosenburg, CEO and co-founder of SBP.
  • The Clinton Global Initiative (CGI) convenes global and emerging leaders to create and implement solutions to the world's most pressing challenges.

New Study Published in an American Heart Association Journal Indicates that Hello Heart’s Digital Coaching App Could Contribute to Heart Health Equity

Retrieved on: 
Wednesday, September 21, 2022
Cardiology, Telemedicine, Virtual Medicine, General Health, Health, Health Technology, Technology, Apps, Applications, Other Health, Health, Therapy, Profile, Time, Hypertension, Digital therapeutics, Blood pressure, Woman, Risk, MD, Prevalence, Language, Self-management, Health equity, DEI, SBP, Degenerative disease, Beaumont Health, Program, White, CEO, Organization, MBA, CDC, Sex, Infarction, Surgeon, Doctor of Philosophy, Ecosystem, American Heart, Behavior, Black, Heart, Fortune 500, Surgeon General of California, Mortality, AI, Man, Education, Death, Female, Pharmaceutical industry, Medical device, Cardiology, Telemedicine, Virtual Medicine, General Health, Health, Health Technology, Technology, Apps, Applications, Other Health

The study, published as an abstract in the American Heart Associations Hypertension journal, indicates that Hello Hearts hypertension digital coaching program could contribute to health equity, showing similar improvements in heart health for a range of populations, across gender, age, race, and more.

Key Points: 
  • The study, published as an abstract in the American Heart Associations Hypertension journal, indicates that Hello Hearts hypertension digital coaching program could contribute to health equity, showing similar improvements in heart health for a range of populations, across gender, age, race, and more.
  • Closing the gaps in hypertension care is critical to help mitigate the impact of social determinants of health (SDoH) on heart health.
  • The data suggests that Hello Hearts digital coaching tools have the potential to contribute to health equity in hypertension outcomes, especially in women.
  • This important study suggests that digital therapeutics could help level the playing field when it comes to heart health.